Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Macrophage Migration Inhibition Test using Guinea-pig Macrophages and Human Lymphocytes

Abstract

THE capillary macrophage migration inhibition test1,2, one of the few available satisfactory methods for the in vitro study of delayed hypersensitivity, has largely remained an animal experimental technique, for a ready source of human macrophages has not been available. The usefulness of the method has thus been limited. Attempts by Lawrence and David3 to use human, blood cells were fraught with technical difficulties and therefore apparently abandoned. The subsequent isolation of migration inhibition factor4,5 diverted attention to the study of its properties. For example, when the factor was obtained from sensitive human lymphocytes it could inhibit guinea-pig macrophages6, but exploitation of this property did not increase significantly the study of human delayed hypersensitivity. The absence of sufficient macrophages (monocytes) in human peripheral blood for the test to be carried out successfully was overcome by culturing lymph node cells for 72 h and then performing the usual capillary migration test7. None of these modifications has had wide application because of numerous practical difficulties brought on by further complication of an already difficult technique. The case of peripheral blood cells8 failed to stand up to critical testing9. We wish to make a preliminary report of a successful method for the capillary migration inhibition test using guinea-pig macrophages and human peripheral blood lymphocytes. Fuller details of the technique, in view of its possible wide application in the study of human disease, will be published later.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. George, M., and Vaughan, J. H., Proc. Soc. Exp. Biol. and Med., 111, 514 (1962).

    Article  CAS  Google Scholar 

  2. David, J. R., J. Exp. Med., 122, 1125 (1965).

    Article  CAS  Google Scholar 

  3. Lawrence, H. S., Fed. Proc., 27, 3 (1968).

    CAS  PubMed  Google Scholar 

  4. Bloom, B. R., and Bennett, B., Science, 153, 80 (1966).

    Article  ADS  CAS  Google Scholar 

  5. David, J. R., Proc. US Nat. Acad. Sci., 56, 72 (1966).

    Article  ADS  CAS  Google Scholar 

  6. Thor, D. E., Juveziz, R. E., Veach, S. R., Miller, E., and Dray, S., Nature, 219, 755 (1968).

    Article  ADS  CAS  Google Scholar 

  7. Thor, D. E., Fed. Proc., 27, 16 (1968).

    CAS  PubMed  Google Scholar 

  8. Søborg, M., Acta Med. Scand., 184, 135 (1968).

    Article  Google Scholar 

  9. Kaltreider, H. B., Soghor, D., Taylor, J. B., and Dekev, J. L., J. Immunol., 103, 179 (1969).

    CAS  PubMed  Google Scholar 

  10. Coulson, A. S., and Chalmers, D. G., Lancet, i, 468 (1964).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

RAJAPAKSE, D., GLYNN, L. Macrophage Migration Inhibition Test using Guinea-pig Macrophages and Human Lymphocytes. Nature 226, 857–858 (1970). https://doi.org/10.1038/226857a0

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1038/226857a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing